Trials / Unknown
UnknownNCT04831619
Contribution of PET (Positron Emission Tomography) Scans for the Preoperative Assessment of Symptomatic Endometriosis Lesions: TEP-ENDORUN
Contribution of PET Scans for the Preoperative Assessment of Symptomatic Endometriosis Lesions: TEP-ENDORUN
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de la Réunion · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Endometriosis is an inflammatory condition that is often treated by surgery. MRI and ultrasound are used for the preoperative morphological assessment. Currently, only surgery allows the exhaustive and qualitative diagnosis of lesions. The PET scan, fixing in certain inflammatory pathologies and in certain cases of endometriosis, could refine this assessment by evaluating the location of the lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PET scanner with injection of 18 FDG (18F-2-fluoro-2-deoxy-D-glucose) (radiolabel) | A PET scan will be performed in the patients included, in addition to the conventional imaging workup (MRI, endovaginal and pelvic ultrasound). |
Timeline
- Start date
- 2022-05-01
- Primary completion
- 2023-05-01
- Completion
- 2024-09-30
- First posted
- 2021-04-05
- Last updated
- 2022-03-02
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04831619. Inclusion in this directory is not an endorsement.